ASCENSION SETON BASTROP — History
CCN 670143 | 3-year financial timeline | COVID resilience: 75/100
🛡️ Public data only — no PHI permitted on this instance.
$17M
Latest Revenue (FY2022)
+22.8%
Revenue CAGR (3yr)
12.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $11M | $15M | $17M | +7.7% | +22.8% |
| Operating Expenses | $10M | $14M | $15M | +4.7% | +19.2% |
| Operating Margin | 7.0% | 9.8% | 12.2% | +25.3% | +32.4% |
| Net Income | $1M | $2M | $2M | +34.9% | +62.5% |
| Licensed Beds | 7 | 7 | 7 | +0.0% | +0.0% |
| Total Patient Days | 579 | 774 | 342 | -55.8% | -23.1% |
| Medicare Day % | 24% | 24% | 44% | +78.4% | +33.8% |
| Medicaid Day % | 1% | nan% | 0% | +nan% | -54.0% |
COVID Impact & Recovery
Resilience Score: 75/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +50.7% ($11M → $17M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+22.8%
This Hospital
+7.6%
State Avg
Latest Margin
12.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $19M | 14.8% |
| FY2024 (proj) | $22M | 17.5% |
| FY2025 (proj) | $25M | 20.1% |